PlasmaCord
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- PlasmaCord
- Accession Number
- DB16363
- Description
PlasmaCord is platelet-poor plasma that is derived by fractionation from sterile umbilical cord and placental blood.1 It is developed by Cellpraxis and is currently being investigated against severe acute respiratory syndrome (SARS).
- Type
- Biotech
- Groups
- Investigational
- Synonyms
- Human umbilical cord and placental blood plasma
- External IDs
- PlasmaCord
Pharmacology
- Indication
- Not Available
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
References
- General References
- CellPraxis: PlasmaCord® [Link]
- External Links
- Not Available
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on December 17, 2020 15:22 / Updated on December 22, 2020 18:31